Rachel Tan1, Biljana Cvetkovski2, Vicky Kritikos2, David Price3, Kwok Yan4, Peter Smith5, Sinthia Bosnic-Anticevich6. 1. Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia. Electronic address: stan6464@uni.sydney.edu.au. 2. Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia. 3. Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom; Observational and Pragmatic Research Institute Pte Ltd, Singapore. 4. Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. 5. Clinical Medicine, Griffith University, Southport, Queensland, Australia. 6. Quality Use of Respiratory Medicine Group, Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia; Sydney Local Health District, Sydney, New South Wales, Australia.
Abstract
BACKGROUND: The burden of rhinitis is high. It is unknown to what extent this burden is related to inappropriate medication use. OBJECTIVE: This study aimed to identify the way in which people with rhinitis medicate their condition and to evaluate the appropriateness of this medication management. METHODS: Pharmacy customers who visited Sydney metropolitan community pharmacies and purchased medication for nasal symptoms were the sampling frame for this study. To determine the condition for which the participants were seeking medication and the appropriateness of their medication selection, the following data were collected with a researcher-administered questionnaire: participant's demographics, symptoms, medication selected. An expert panel of clinical researcher pharmacists and specialist respiratory physician evaluated the appropriateness of medication selection based on the Allergic Rhinitis and its Impact on Asthma international guidelines. RESULTS: Two hundred and ninety-six participants were recruited from 8 pharmacies; 63.2% had a doctor's diagnosis for the symptoms for which they were selecting treatment. Seventy percent of participants self-selected their medications. Seventy-one percent of the participants were identified as having rhinitis. Overall, 16.5% of participants who had rhinitis selected optimal medications. Sixteen percent of participants with allergic rhinitis reported wheezing (6.3% selected optimal medications). CONCLUSIONS: The majority of the participants with rhinitis selected suboptimal medications from community pharmacy highlighting the significant burden of rhinitis in community pharmacy and the contribution of medication management. Pharmacists need to take a proactive and evidence-based role in the management of rhinitis supported by clinical pathways when need to be articulated and promoted in all rhinitis guidelines.
BACKGROUND: The burden of rhinitis is high. It is unknown to what extent this burden is related to inappropriate medication use. OBJECTIVE: This study aimed to identify the way in which people with rhinitis medicate their condition and to evaluate the appropriateness of this medication management. METHODS: Pharmacy customers who visited Sydney metropolitan community pharmacies and purchased medication for nasal symptoms were the sampling frame for this study. To determine the condition for which the participants were seeking medication and the appropriateness of their medication selection, the following data were collected with a researcher-administered questionnaire: participant's demographics, symptoms, medication selected. An expert panel of clinical researcher pharmacists and specialist respiratory physician evaluated the appropriateness of medication selection based on the Allergic Rhinitis and its Impact on Asthma international guidelines. RESULTS: Two hundred and ninety-six participants were recruited from 8 pharmacies; 63.2% had a doctor's diagnosis for the symptoms for which they were selecting treatment. Seventy percent of participants self-selected their medications. Seventy-one percent of the participants were identified as having rhinitis. Overall, 16.5% of participants who had rhinitis selected optimal medications. Sixteen percent of participants with allergic rhinitis reported wheezing (6.3% selected optimal medications). CONCLUSIONS: The majority of the participants with rhinitis selected suboptimal medications from community pharmacy highlighting the significant burden of rhinitis in community pharmacy and the contribution of medication management. Pharmacists need to take a proactive and evidence-based role in the management of rhinitis supported by clinical pathways when need to be articulated and promoted in all rhinitis guidelines.
Authors: Juha Markus Heikkilä; Paula Bergman; Juha Jantunen; Johanna Salimäki; Paula Kauppi; Marika Pohjanoksa-Mäntylä Journal: Explor Res Clin Soc Pharm Date: 2021-06-24
Authors: Olga Lourenço; Biljana Cvetkovski; Vicky Kritikos; Rachel House; Sophie Scheire; Elisio M Costa; João A Fonseca; Enrica Menditto; Anna Bedbrook; Slawomir Bialek; Vitalis Briedis; Koen Boussery; G Walter Canonica; Tari Haahtela; Piotr Kuna; Joaquim Mullol; Valentina Orlando; Boleslaw Samolinski; Dana Wallace; Catherine Duggan; Ema Paulino; Gonçalo S Pinto; Lars-Åke Söderlund; Jean Bousquet; Sinthia Bosnic-Anticevich Journal: Clin Transl Allergy Date: 2022-10-05 Impact factor: 5.657